News
ASID President Professor Joseph Doyle begins term
Professor Joseph Doyle new ASID President
Professor Joseph Doyle honoured with 2024 Frank Fenner Award
Professor Joseph Doyle honoured with 2024 Frank Fenner Award
ANZPID submission to the Commonwealth Government COVID-19 Response Inquiry
ANZPID Commonwealth Government COVID-19 Response Inquiry
ASID submission to the Commonwealth Government COVID-19 Response Inquiry
ASID Commonwealth Government COVID-19 Response Inquiry
Aboriginal and Torres Strait Islander Voice to Parliament will improve infectious diseases health outcomes
Aboriginal and Torres Strait Islander Voice to Parliament will improve infectious diseases health outcomes
Professor Monica Slavin receives 2023 ASID Life Member Award
Prof Monica Slavin receives 2023 ASID Life Member Award
Adelaide gets ready to host major medical conference: ASID ASM 2023
Adelaide gets ready to host major medical conference - ASID ASM 2023
ASID outlines how Australia’s considerable infectious diseases and public health expertise could be harnessed by a national CDC.
ASID members have played many roles during the COVID-19 pandemic at a national, state and local level, and are a trusted source of information for the community. The society has advocated for a national centre for disease control for many years, and broadly supports the mission and purpose outlined in the consultation document.
ANZPID Submission: Inquiry into Long COVID and Repeated COVID Infections
The Australian and New Zealand Paediatric Infectious Diseases Group (ANZPID) of the Australasian Society for Infectious Diseases (ASID) advocates for prioritised understanding and delivery of coordinated support to children and young people affected by post-COVID conditions, including long COVID.
Viral Hepatitis Special Interest Group supports national response to eliminate hepatitis B and hepatitis C by 2030 28 July 2022
Viral Hepatitis Special Interest Group supports national response to eliminate hepatitis B and hepatitis C by 2030 28 July 2022
ASID Special Interest Groups support ATAGI advice on COVID-19 vaccinations for children aged 6 months to <5 years old in Australia.
ASID Special Interest Groups support ATAGI advice on COVID-19 vaccinations for children aged 6 months to <5 years old in Australia
All children over six months of age should get the influenza vaccine: Australian and New Zealand Paediatric Infectious Diseases Group
The Australian and New Zealand Paediatric Infectious Diseases Group (ANZPID) of the Australasian Society for Infectious Diseases (ASID) strongly supports the recommendations of the Australian Technical Advisory Group on Immunisation (ATAGI) for all children over six months of age to receive the influenza vaccine, which is currently available throughout Australia and Aotearoa/New Zealand.